Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06471322 · ClinicalTrials.gov registry record · NA
A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes
A NA study, sponsored by The Cleveland Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06471322 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 2 participants.
The verdict
NCT06471322, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The study team proposes that use of a novel multi-disciplinary approach with continuous glucose monitoring technology can significantly improve glycemic control and reduce readmissions among those with type 1 diabetes mellitus (T1DM) admitted for Diabetic ketoacidosis (DKA). This will also help promote a pathway for care of these patients after admission utilizing resources which are available within the Endocrinology, Diabetes and Metabolism department at the Cleveland Clinic.
Interventions
- OTHER Standard of Care
- DEVICE Continuous Glucose Monitoring (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2024-11-15 |
| Est. Completion | 2025-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06471322
The ClinicalTrials.gov registry entry for NCT06471322 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT06471322 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06471322 about?
NCT06471322 is a clinical study titled "A Multi-Disciplinary Technology-Based Care for Diabetic Ketoacidosis in Patients With Type 1 Diabetes". The study team proposes that use of a novel multi-disciplinary approach with continuous glucose monitoring technology can significantly improve glycemic control and reduce readmissions among those with type 1 diabetes mellitus (T1DM) admitted for Diabetic ketoacidosis (DKA). This will also help prom...
What is the current status of trial NCT06471322?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2024-11-15. Estimated completion is 2025-11-01.
What interventions are being tested in trial NCT06471322?
The interventions under investigation include: Standard of Care (OTHER), Continuous Glucose Monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT06471322?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.